Determination of enantiomeric excess by chiral liquid chromatography without enantiomerically pure starting standards

ABSTRACT A facile approach for the enantiomeric excess determination of enantiomeric mixtures without the necessity of pure enantiomer standards is presented. Promethazine and trimeprazine commercial nonracemic mixtures were used as cases study to probe the validity of the method. Chromatographic re...

Full description

Saved in:
Bibliographic Details
Published inBiomedical chromatography Vol. 26; no. 10; pp. 1241 - 1246
Main Authors Sánchez, F. G., Navas Díaz, A., Sánchez Torreño, E., Aguilar, A., Medina Lama, I., Algarra, M.
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.10.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:ABSTRACT A facile approach for the enantiomeric excess determination of enantiomeric mixtures without the necessity of pure enantiomer standards is presented. Promethazine and trimeprazine commercial nonracemic mixtures were used as cases study to probe the validity of the method. Chromatographic resolutions obtained with a chiral column AGP in reverse phase mode were 1.32–1.16 (promethazine) and 1.20–0.93 (trimeprazine) for the three detectors (circular dichroism, photometric and fluorimetric) in series. Results obtained showed that enantiomeric excess was 10.4, 8.71 and 8.58% for promethazine and 1.60, 1.23 and 1.80% for trimeprazine (medium values of 9.23 ± 1.01% and 1.54 ± 0.29%, respectively). Recovery assay over human serum samples, at three concentration levels, spiked with prometazine and submitted to solid‐phase extraction, gave values of 99.09–93.48% [S‐(−) enantiomer] and 98.51–91.89% [R‐(+)‐enantiomer]. Detection limits of promethazine enantiomers were between 0.02 µg (fluorimetric) and 1 µg (circular dichroism), and 0.02–1.1 µg for trimeprazine. Copyright © 2012 John Wiley & Sons, Ltd.
Bibliography:ark:/67375/WNG-JCTG7GRT-5
ArticleID:BMC2685
istex:E1C196974834C9EA279592D73FECAA8306EE37C4
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0269-3879
1099-0801
DOI:10.1002/bmc.2685